Pathward's Julie Halbert Named a Trailblazer by National Publication
BATON ROUGE, La., May 28, 2025--(BUSINESS WIRE)--Pathward®, N.A., a financial empowerment company driven by its purpose to power financial inclusion, today announced that ABF Journal has named Julie Halbert, a Portfolio Manager for the Commercial Finance business line, to its list of Trailblazers. The award recognizes leading women in specialty finance who are redefining the industry.
"Not only has Julie enjoyed a long-tenured career in specialty finance leading people in a successful organization, but also she has held a variety of positions that equip her with an extensive depth and breadth of knowledge that she brings to her current role at Pathward," said Christopher Soupal, Pathward Divisional President and Revenue Lending Officer. "She has been instrumental in the continual strategy, employee development and performance of the Working Capital team at Pathward, and we are thrilled to see her recognized for her contributions to our organization and industry at large."
Halbert brings nearly three decades of commercial banking experience to her role as Portfolio Manager for Pathward's working capital group. She began her career as a field examiner in 1993 and later became a portfolio manager before joining Pathward (formerly Crestmark Bank) in 2009 as an underwriter. From there, she became the underwriter manager for the Western Division and later moved into her role in portfolio management. Today, she leads a team of 30 and has control of planning, staffing, budgeting, managing expense priorities, and recommending and implementing changes to methods for an asset based commercial loan portfolio approaching $1 billion in total assets. Halbert resides in Baton Rouge, Louisiana.
"I'm honored by this recognition and Pathward's confidence in my amazing team and me," said Halbert. "I benefited greatly from working in nearly every position in an asset-based lending shop, and it taught me so much about the business, to include empathy and respect for various roles. My advice for others in the industry would be to develop a network of mentors and peers who you can learn from and trust, seek help when you need it, listen and stay curious."
Read Halbert's profile published in the May 2025 issue of ABF Journal at ABFJournal.com.
About Pathward®
Pathward®, N.A., a national bank, is a subsidiary of Pathward Financial, Inc. (Nasdaq: CASH). Pathward is a U.S.-based financial empowerment company driven by its purpose to power financial inclusion. Pathward strives to increase financial availability, choice and opportunity across our Partner Solutions and Commercial Finance business lines. The strategic business lines provide support to individuals and businesses. Learn more at Pathward.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528450114/en/
Contacts
Media contact: Courtney Heidelberg605.291.7044mediarelations@pathward.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Medpace (MEDP) Q2 Earnings Report Preview: What To Look For
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting results this Monday after market hours. Here's what to expect. Medpace beat analysts' revenue expectations by 6% last quarter, reporting revenues of $558.6 million, up 9.3% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' organic revenue estimates and an impressive beat of analysts' EPS estimates. Is Medpace a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Medpace's revenue to grow 2.6% year on year to $542 million, slowing from the 14.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $3.00 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Medpace has missed Wall Street's revenue estimates five times over the last two years. With Medpace being the first among its peers to report earnings this season, we don't have anywhere else to look to get a hint at how this quarter will unravel for life sciences tools & services stocks. However, the whole sector has been hit hard over the last month as stocks in Medpace's peer group are down 2.5% on average. Medpace's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $301.61 (compared to the current share price of $311.86). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Earnings To Watch: Preferred Bank (PFBC) Reports Q2 Results Tomorrow
Commercial banking company Preferred Bank (NASDAQ:PFBC) will be announcing earnings results this Monday before market open. Here's what investors should know. Preferred Bank missed analysts' revenue expectations by 5.5% last quarter, reporting revenues of $66.66 million, down 6.9% year on year. It was a disappointing quarter for the company, with a significant miss of analysts' net interest income estimates and a miss of analysts' EPS estimates. Is Preferred Bank a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Preferred Bank's revenue to grow 1.9% year on year to $70.82 million, a reversal from the 9% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.43 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Preferred Bank has missed Wall Street's revenue estimates three times over the last two years. Looking at Preferred Bank's peers in the regional banks segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Texas Capital Bank delivered year-on-year revenue growth of 15.2%, beating analysts' expectations by 2.7%, and Nicolet Bankshares reported revenues up 12.7%, topping estimates by 4.4%. Texas Capital Bank traded up 4.8% following the results while Nicolet Bankshares was also up 7.8%. Read our full analysis of Texas Capital Bank's results here and Nicolet Bankshares's results here. There has been positive sentiment among investors in the regional banks segment, with share prices up 10.3% on average over the last month. Preferred Bank is up 13.8% during the same time and is heading into earnings with an average analyst price target of $93.75 (compared to the current share price of $92.61). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
an hour ago
- Yahoo
BOK Financial (BOKF) Q2 Earnings: What To Expect
Regional banking company BOK Financial (NASDAQ:BOKF) will be reporting earnings this Monday after the bell. Here's what you need to know. BOK Financial missed analysts' revenue expectations by 3.2% last quarter, reporting revenues of $502.3 million, up 9.8% year on year. It was a softer quarter for the company, with a significant miss of analysts' EPS estimates and net interest income in line with analysts' estimates. Is BOK Financial a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting BOK Financial's revenue to decline 7.1% year on year to $518.4 million, a reversal from the 4.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.99 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. BOK Financial has missed Wall Street's revenue estimates three times over the last two years. Looking at BOK Financial's peers in the regional banks segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Texas Capital Bank delivered year-on-year revenue growth of 15.2%, beating analysts' expectations by 2.7%, and Nicolet Bankshares reported revenues up 12.7%, topping estimates by 4.4%. Texas Capital Bank traded up 4.8% following the results while Nicolet Bankshares was also up 7.8%. Read our full analysis of Texas Capital Bank's results here and Nicolet Bankshares's results here. There has been positive sentiment among investors in the regional banks segment, with share prices up 10.3% on average over the last month. BOK Financial is up 14.3% during the same time and is heading into earnings with an average analyst price target of $106.60 (compared to the current share price of $105.99). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
